HNN3.0
Register
Register
Register

University of Galway

University

www.universityofgalway.ie/Galway, Ireland

About

The University of Galway is a public research university located in Galway, in the west of Ireland. The University was founded in 1845 and started with just 68 students. Since then, we have grown to teach a student population today of over 19,000. Over the past decade, we have been steadily increasing our global reach and reputation. According to QS World University Rankings, we are now ranked in the top 2% of universities worldwide and the top 100 universities in Europe. Ranked Ireland's #1 university for sustainable development in the Times Higher Education World Rankings (THE).

At University of Galway, we have a thriving research community, contributing to the biomedical ecosystem in the West of Ireland. Our research is driven by the ambition to benefit society and the planet. We focus on global challenges, national priorities, and regional needs — delivering distinctive impact through research excellence. Our people are the heart of our research. They are creative thinkers and problem-solvers whose engaged approach and interdisciplinarity drives excellence, sparks global partnerships, and amplifies impact. Galway is a hub of creativity and innovation — home to a vibrant research culture and a thriving start-up community. From our dynamic research ecosystem, we collaborate with 5,000+ institutions in 178 countries, working across disciplines and borders to deliver world-class impact.

Representatives

Lecturer in Glycosciences

University of Galway

Marketplace (2)

  • Project cooperation

    Rapid immune response novel platform, animal free

    A novel HTP platform to profile immune response (antibody response to antigens, effector function) which incorporates genetic variability.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    Author

    Lecturer in Glycosciences at University of Galway

    Galway, Ireland

  • Project cooperation

    Rapid immune response novel platform, diagnostics prognostics

    Novel HTP platform to profile immune response (antibody response to antigens, effector function) incorporating genetic variability

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    Author

    Lecturer in Glycosciences at University of Galway

    Galway, Ireland